Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia
Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia
Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia
Submitted by
admin
on December 24, 2008 - 10:31am
Source:
Yahoo
News Tags:
Memory Pharmaceuticals
schizophrenia
Headline:
Memory Pharmaceuticals Initiates Biomarker Study of R3487/MEM 3454 in Schizophrenia
Do Not Allow Advertisers to Use My Personal information
